Revelyx Bio

DE · Founded 2025 · Privately Held (backing)

Developer of a botulinum toxin liquid formulation designed to bring a new anti-aging and medical experience characterized by efficacy. Revelyx Bio is based in DE and was founded in 2025. Its last reported valuation was $110 million in Jan 2026. It has raised $10.4 million.

Last reported valuation

$109.5M

Oct 2026

Priced at

—

Total raised

$10.4M

Last round

—

How much has Revelyx Bio raised?

$10.4Macross 0 recorded rounds

Free account

More of Revelyx Bio with a free account

·Watch Revelyx Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Revelyx Bio investors

1 investor is on record for Revelyx Bio, including NRL Capital.

For fundraisers

Raising for a company like Revelyx Bio?

1 investors have backed Revelyx Bio.

See all 1 investors →

Frequently asked about Revelyx Bio

How much has Revelyx Bio raised?: Revelyx Bio has raised $10.4M in total across 0 recorded funding rounds.